Opioid overdose treatment involves the use of pharmaceutical drugs and therapies to reverse the effects of opioids during an opioid overdose. Some common treatments for opioid overdose include naloxone, buprenorphine, and methadone. Naloxone is considered the frontline treatment for reversing opioid overdose as it works by blocking opioid receptors and reverting the life-threatening depression of the central nervous and respiratory systems. The need for opioid overdose treatment has been growing due to the rising misuse of prescription and illegal opioids. According to the National Institute on Drug Abuse, more than 500,000 Americans died from drug overdoses during 1999-2019, with 70% of these deaths involving an opioid.

The Global Opioid Overdose Treatment Market is estimated to be valued at US$ 45.9 Bn in 2024 and is expected to exhibit a CAGR of 6.1% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Opioid Overdose Treatment are Enalare Therapeutics Inc., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Emergent BioSolutions, Purdue Pharma. Enalare Therapeutics is developing a novel intranasal nalmefene formulation to reverse opioid overdoses. Opiant Pharmaceuticals' lead opioid overdose drug, Narcan Nasal Spray, received regulatory approvals in the United States and Europe.

The key opportunities in the opioid overdose treatment market include the commercialization of emerging pipeline drugs with enhanced safety profiles and abuse-deterrent formulations. There is also a need to develop innovative delivery mechanisms for opioid antagonists to allow for self- or community-administration during opioid emergencies.

The market is witnessing significant expansion outside the United States as well. Several countries in Europe, Asia Pacific, Latin America, Middle East, and Africa are also impacted by the increasing opioid crisis. This has accelerated the adoption of opioid overdose treatment medications across international markets.

Market drivers

The growing availability and misuse of both prescription and illegal opioids is a key driver augmenting the need for opioid overdose treatments. According to CDC data, prescription opioids were involved in more than 17,000 overdose deaths in 2017 alone. This rising wave of opioid abuse and overdoses has increased the demand for opioid overdose reversal drugs. Moreover, the guidelines emphasizing increased naloxone access and broader prescription of naloxone to high-risk groups will continue driving market revenues.

Market restraints

Lack of opioid antagonist access in developing countries pose a major restraint. Naloxone availability remains limited in low and middle-income nations where the disease burden is also significant. The high costs associated with branded opioid overdose drugs also restrain market potential, necessitating generic competition and value-based pricing strategies. Non-acceptance of opioid dependence as a public health issue by certain regional governments further impedes market progress.

Segment Analysis
The opioid overdose treatment market is segmented based on treatment type into nasal spray drugs, injection drugs, and others. Among these, the injection drugs segment dominates currently as Naloxone is widely used in injection form to treat opioid overdose in emergency situations. Naloxone in injection form gets absorbed into the body quickly to reverse overdose effects within 2-5 minutes.

Global Analysis
The North America region dominates the global opioid overdose treatment market currently. This is due to the increasing number of opioid overdoses in the US. According to CDC data, over 100,000 drug overdose deaths were reported in the US in 2021, out of which majority involved opioids. The emergency medical services and first responders in the US extensively use naloxone in injection form to rapidly reverse overdoses. Europe is also a major regional market and is expected to witness fastest growth during the forecast period due to growing availability of easy-to-administer formulations such as nasal spray drugs for opioid overdose reversal in several European countries.

Get more insights on this topic : https://justpaste.it/hruqm

What Are The Key Data Covered In This Opioid Overdose Treatment  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Opioid Overdose Treatment 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Opioid Overdose Treatment  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Opioid Overdose Treatment  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Opioid Overdose Treatment  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it